Partnerships
ARSC - Regional Health Administration of the Centre Region, IP
http://www.arscentro.min-saude.pt/Paginas/Inicio.aspxThe ARSC has a Protocol with the AIBILI which is of great relevance to AIBILI. The area of primary health care is a major research interest of AIBILI. There is an ongoing collaboration is screening programmes and epidemiological studies.
Associate Laboratory of the Portuguese Foundation for Science and Technology
http://www.fct.mctes.pt/labs/associados/index.asp?dados=true&lista=2&valor=1AIBILI is partner of the CNC – Centre of Neuroscience and Cell Biology of the University of Coimbra, as an Associate Laboratory of the Portuguese Foundation for Science and Technology (FCT).
As a complement to CNC laboratory research activities and taking into consideration pharmaceutical industry needs, AIBILI performs clinical research necessary for the effective translational research and physical-chemical testing services to industry.
Champalimaud Foundation
http://www.fchampalimaud.org/The Champalimaud Foundation has established with AIBILI a collaboration by supporting AIBILI translational clinical research activities as a C-Tracer, Champalimaud Translational Research Centre for Eye Research.
Critical Health
http://www.critical-health.comA partnership with the company Critical Health, SA was established in order to bring into the market new medical imaging products developed by AIBILI for the areas of Health Care and Medical Solutions.
Retmarker is a software that provides information to monitor the progression of retinal diseases, which are the leading causes of blindness in the Western world.
Retmarker is in the international market and is a good example of the success in this partnership.
More information: www.retmarker.com
EVI – European Vision Institute
http://www.europeanvisioninstitute.orgThe aim of EVI is to devise and implement programs and projects for new therapeutic strategies for eye diseases that are difficult or impossible to treat currently. Its approach will incorporate the most recent scientific developments of the postgenomic area. EVI is targeted towards the more immediate policy objectives of improving the competitiveness of European research by assembling the leading institutions (with partners) from industry and academia.
EVI integrates, conducts and supports research that helps to prevent and treat eye diseases and other disorders of vision. This research leads to sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life for people of all ages.
AIBILI is a founding member of EVI since 2003 together with 3 other research institutes from Tübingen, Paris and London.
EVI main office is located in Brussels and the Branch Office at AIBILI, in Coimbra, Portugal is responsible for the Clinical Research area.
Faculty of Medicine of the Coimbra University
http://www.uc.pt/fmucAIBILI has a close relationship with the Faculty of Medicine of the University of Coimbra and in 2010 a Protocol was signed between the two institutions and aims to enhance the conditions for research, innovation, expertise services, knowledge transfer and training in the health sciences area.
IBILI - Institute of Biomedical Research on Light and Image
http://www.ibili.uc.ptWithin the Faculty of Medicine AIBILI has particular scientific relationship with the Institute of Biomedical Research on Light and Image (IBILI). IBILI is a basic research institute focused on Visual Sciences. It has six main Laboratory Units: Biology of Ageing; Functional Genomics; Cell Biology of Retinal Disease; Retinal Imaging; Visual Psychophysiology; Clinical Research. The Technology Transfer Unit of AIBILI is responsible to perform technology transfer of the research developed in IBILI.
IBILI is evaluated regularly by an independent international panel from the Portuguese Foundation for Science and Technology (FCT) and has been evaluated since 1999 as "Excellent".
INFARMED - National Authority of Medicines and Health Products, IP
http://www.infarmed.pt/portal/page/portal/INFARMEDAIBILI has a Protocol signed with INFARMED since 2001. In order to implement collaborative projects with INFARMED was signed in 2010 an Addendum to the Protocol between AIBILI and INFARMED providing thus a greater relationship in areas of pharmacovigilance, pharmacoeconomics, studies of market monitoring and utilization studies drugs, bioavailability/bioequivalence; activities in clinical trials and reading centre image classification.
University Hospital of Coimbra - Centre of Responsibility in Ophthalmology
http://www.huc.min-saude.ptAIBILI has a Protocol signed with the Coimbra University Hospital since 1994 for mutual collaboration.
In 2010 an addendum to this Protocol was signed with the Centre of Responsibility in Ophthalmology of the Coimbra University Hospital (CRIO-HUC) stating the collaboration between the institutions in clinical research, ophthalmologic consultations and examinations, internationalization, technological support and training.
Contacts
Azinhaga Sta. Comba, Celas
3000-548 Coimbra
Portugal
Geographical coordinates:
40º 13' 06,24" N
8º 24' 54,83" O
Telephone: +351 239 480100
Fax: +351 239 480117
E-mail: aibili@aibili.pt